Last updated: 20 July 2019 at 5:49am EST

David J. Lundquist Net Worth




The estimated Net Worth of David J. Lundquist is at least 312 千$ dollars as of 16 November 2011. David Lundquist owns over 15,000 units of Lumos Pharma Inc stock worth over 311,963$ and over the last 13 years David sold LUMO stock worth over 0$.

David Lundquist LUMO stock SEC Form 4 insiders trading

David has made over 1 trades of the Lumos Pharma Inc stock since 2011, according to the Form 4 filled with the SEC. Most recently David bought 15,000 units of LUMO stock worth 105,000$ on 16 November 2011.

The largest trade David's ever made was buying 15,000 units of Lumos Pharma Inc stock on 16 November 2011 worth over 105,000$. On average, David trades about 15,000 units every 0 days since 2011. As of 16 November 2011 David still owns at least 87,630 units of Lumos Pharma Inc stock.

You can see the complete history of David Lundquist stock trades at the bottom of the page.



What's David Lundquist's mailing address?

David's mailing address filed with the SEC is C/O NEWLINK GENETICS CORPORATION, 2503 SOUTH LOOP DR., SUITE 5100, AMES, IA, 50010.

Insiders trading at Lumos Pharma Inc

Over the last 13 years, insiders at Lumos Pharma Inc have traded over 6,087,405$ worth of Lumos Pharma Inc stock and bought 2,157,996 units worth 15,106,881$ . The most active insiders traders include Seed Farm, Inc. StinePaul R EdickCharles J. Jr. Link. On average, Lumos Pharma Inc executives and independent directors trade stock every 257 days with the average trade being worth of 694,335$. The most recent stock trade was executed by James E Deerfield Mgmt Iii,... on 6 January 2021, trading 151,723 units of LUMO stock currently worth 3,425,905$.



What does Lumos Pharma Inc do?

lumos pharma is an clinical stage biotechnology company focused on developing therapeutics for rare diseases



Complete history of David Lundquist stock trades at Lumos Pharma Inc

インサイダー
取引
取引
合計金額
David J. Lundquist
ディレクター
購入する 105,000$
16 Nov 2011


Lumos Pharma Inc executives and stock owners

Lumos Pharma Inc executives and other stock owners filed with the SEC include: